Cargando…

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening

OBJECTIVE: To evaluate the efficiency of p16/Ki-67 dual stain used as a triage in cervical cancer screening. METHODS: In this study, we did 468 p16/Ki-67 dual stain in human papillomavirus (HPV) 16/18-positive or 12 other high-risk HPV (OHR-HPV) positive Thinprep cytologic test (TCT) atypical squamo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Qin, Guo, Hongyan, Geng, Li, Wang, Yanjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219095/ https://www.ncbi.nlm.nih.gov/pubmed/32410798 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.08

Ejemplares similares

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening
por: Dovnik, Andraž, et al.
Publicado: (2023)

p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya
por: Ngugi, Caroline Wangari, et al.
Publicado: (2015)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
por: Stoler, Mark H., et al.
Publicado: (2019)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining
por: Robial, R., et al.
Publicado: (2017)

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
por: Wentzensen, Nicolas, et al.
Publicado: (2019)

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2023)

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
por: Harper, Diane M., et al.
Publicado: (2023)

Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020)

Evaluation of the Training Program for p16/ Ki-67 Dual Immunocytochemical Staining Interpretation for Laboratory Staff Without Experience in Cervical Cytology and Immunocytochemistry
por: Prevodnik, Veronika Kloboves, et al.
Publicado: (2020)

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears
por: Kloboves Prevodnik, Veronika, et al.
Publicado: (2019)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China
por: Yu, Lu-Lu, et al.
Publicado: (2016)

Human Papillomavirus Detection and Abnormal Anal Cytology in HIV-infected Patients Using p16/Ki-67 Dual-Staining
por: Patarapadungkit, Natcha, et al.
Publicado: (2020)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16(INK4a)/Ki-67 dual stain cytology in Western Kenya
por: Orang’o, Elkanah Omenge, et al.
Publicado: (2020)

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
por: Tantitamit, Tanitra, et al.
Publicado: (2020)

A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec(®) PLUS p16/Ki-67 Dual Stain in Triaging HPV-Positive Women
por: Li, Ying, et al.
Publicado: (2022)

Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)–Study protocol
por: Okunade, Kehinde S., et al.
Publicado: (2023)

Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors
por: Das, Diya, et al.
Publicado: (2018)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Validation of an on-chip p16(ink4a)/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology
por: Hashimoto, Kei, et al.
Publicado: (2023)

The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions
por: Magkana, Maria, et al.
Publicado: (2021)

P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women
por: Aromseree, Sirinart, et al.
Publicado: (2022)

Clinical utility of p16/Ki67 dual‐stain cytology for detection of cervical intraepithelial neoplasia grade two or worse in women with a transformation zone type 3: A cross‐sectional study
por: Gustafson, Line Winther, et al.
Publicado: (2022)

Role of Dual-Staining p16/Ki-67 in the Management of Patients under 30 Years with ASC-US/L-SIL
por: Secosan, Cristina, et al.
Publicado: (2022)

The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics
por: Popiel-Kopaczyk, Aneta, et al.
Publicado: (2023)

Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis
por: Chen, Cheng-Chieh, et al.
Publicado: (2016)

A cocktail of p16(INK4a) and Ki-67, p16(INK4a) and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening
por: Wang, Hai-Rui, et al.
Publicado: (2017)

Performance of p16/Ki67 Immunostaining for Triage of Elderly Women with Atypical Squamous Cells of Undetermined Significance
por: Bruno, Maria Teresa, et al.
Publicado: (2023)

Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs
por: Desai, Fanny, et al.
Publicado: (2019)

Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues
por: Xing, Yan, et al.
Publicado: (2017)

Preliminary Study on the Expression of Testin, p16 and Ki-67 in the Cervical Intraepithelial Neoplasia
por: Popiel, Aneta, et al.
Publicado: (2021)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
por: Li, Yuejie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2h9mtu7kvk1h0ght324muqvbpd